lululemon athletica inc. (0JVT)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 103.30 |
|---|---|
| 52-week range | 90.44 – 225.49 |
| Return, 1 month / 3 months | +2.8% / −12.2% |
| Return, 1 year / 3 years | −43.2% / −73.2% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -57.9% |
| Average daily value traded | 1.23M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
lululemon athletica inc. designs and sells athletic apparel and accessories, with a focus on yoga-inspired clothing such as leggings, tops and outerwear for women and men. It also offers footwear and accessories, and runs its own branded stores alongside an online shop and community-based fitness events. The company is based in Vancouver, Canada, and its customers are mainly people who buy technical athletic wear for exercise and everyday use.
On this site lululemon athletica inc. appears as a stock on the London Stock Exchange (UK), code 0JVT, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
lululemon athletica inc. (0JVT) trades on the London Stock Exchange in UK. It last closed at USD 103.30 on 27 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 3,359 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 43.2% and over the last three months it fell 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.2% | ||
| From 52-week high | -52.3% | ||
| Momentum | 14 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.2% | ||
| 6-month return | -29.6% | ||
| 12-month return, skipping the last month | -44.8% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.9% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.23M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +2.8% |
| 3 months | −12.2% |
| 6 months | −29.6% |
| 1 year | −43.2% |
| 3 years | −73.2% |
| 5 years | −76.4% |
Signals
| 50-day / 200-day average | 103.65 / 134.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.09 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.